<DOC>
	<DOCNO>NCT01238224</DOCNO>
	<brief_summary>An increase blood flow capillary permeability decrease impact endothelial barrier glucose insulin allow reach target cell peripheral insulin sensitive organ human body . It well know insulin-resistant type 2 diabetes patient impaired blood flow skeletal muscle therefore important elucidate mean reverse metabolic defect . The investigator recently publish study type 2 diabetes patient use drug erectile dysfunction , PDE-5 inhibitor tadalafil , know effect several vascular territory , increase muscle blood flow type 2 diabetes patient study fast overnight . The aim study test hypothesis tadalafil , compare placebo , increase muscle glucose uptake lower blood glucose follow mixed meal serve type 2 diabetes patient .</brief_summary>
	<brief_title>Effects PDE-5 Inhibition Postprandial Hyperglycemia Type 2 Diabetes</brief_title>
	<detailed_description>An increase blood flow capillary permeability decrease impact endothelial barrier glucose insulin allow reach target cell peripheral insulin sensitive organ human body . It well know insulin-resistant type 2 diabetes patient impaired blood flow skeletal muscle therefore important elucidate mean reverse metabolic defect . The investigator recently publish study type 2 diabetes patient use drug erectile dysfunction , PDE-5 inhibitor tadalafil , know effect several vascular territory , increase muscle blood flow type 2 diabetes patient study fast overnight . In fact , investigator observe tadalafil compare placebo increase glucose uptake muscle parallel augment capillary recruitment muscle . This first publication show pharmacological principle inhibit enzyme phosphodiesterase-5 ( PDE-5 ) may mediate increased muscle glucose uptake , hence , may novel strategy low blood glucose type 2 diabetes patient . The aim study test hypothesis tadalafil , compare placebo , increase muscle glucose uptake lower blood glucose follow mixed meal serve type 2 diabetes patient .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>1 . Postmenopausal state , define natural amenorrhea least 12 month . 2 . Age ; females 5265 year , male : 4065 year . 3 . Type 2 diabetes base fast plasma glucose 2hr glucose OGTT . 4 . Diabetes duration le 5 year . 1 . Patients concurrent use nitrate NO donor , history heart cerebrovascular disease , cardiac failure ( stage NYHA IIIV ) , uncontrolled hypertension ( &gt; 160/100 mm Hg ) , significant diabetic complication , inadequate glycemic control ( HbA1c &gt; 7 % , ref value 3.55.3 % ) 2 . Patients glitazones , insulin , betablockers , ACEinhibitors corticosteroid</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Insulin resistance</keyword>
	<keyword>Phosphodiesterase-5 inhibition</keyword>
	<keyword>Microdialysis</keyword>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Endothelial dysfunction</keyword>
	<keyword>Oral hypoglycaemic agent</keyword>
</DOC>